The Management of Paranoid Schizophrenia by Stramonium in LM Potency-A Case Report

Abstract

Schizophrenia, a chronic mental disorder, disrupts thought processes, perceptions, emotions, and social interactions. Severity varies, with symptoms including hallucinations, delusions, reduced emotional expression, and cognitive difficulties. Global prevalence is 0.3% to 0.7%, emerging in late adolescence or early adulthood, slightly higher in males. Urbanization, migration, genetics, and environmental factors contribute, with varied rates influenced by culture. Recent studies estimate late-onset schizophrenia at 0.33%. Incidence of paranoid schizophrenia is 0.17 per 10,000 individuals, influenced by age and sex.Top of FormA 47-year-old man attended Psychiatry OPD on May 19, 2023, with concerns of poor socialization, sleeplessness, fearfulness, work avoidance, a sensed presence, impending harm, auditory hallucinations, influence perception, and paranoid beliefs persisting for 6 months. Detailed case taking was done on the standardised performa and evaluation was one based on the Kentian method. The repertorization was done using the Synthesis Repertory in RADAR Opus software. Assessment incorporated both the Brief Psychiatric Rating Scale (BPRS) and the Scale for the Assessment of Positive Symptoms (SAPS) over a three-month period. Furthermore, the Modified Naranjo Criteria were applied to assess deeper into causal relationships. The use of homoeopathic LM potencies has demonstrated effectiveness in alleviating symptoms associated with paranoid schizophrenia.